Clinical Trial Update: Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth [NA]

View source ↗

Summary

A completed clinical trial validating HepaFat-Scan as a noninvasive method to measure hepatic steatosis in youth with non-alcoholic fatty liver disease. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Emory University | Conditions: Non-alcoholic Fatty Liver Disease | NA | Status: COMPLETED